Evidence map›Paper›PMID 36915763›Full record

ReviewAmerican journal of translational research2023

Review of FRET biosensing and its application in biomolecular detection.

Chao Fang, Yong Huang, Yongxiang Zhao

Open access · greenAbstract readReview
In one paragraph

Review in American journal of translational research, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
9.6field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 27 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Article
  5. Review
  6. Review
  7. Review
  8. Review
  9. Article
  10. Article
  11. Review
  12. Article
  13. Review
  14. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Chao FangNational Center for International Research of Biotargeting Theranotics, Guangxi Key Laboratory of Biotargeting Theranotics, Collaborative Innovation Center for Targeting Tumor Diagnosis and Therapy, Guangxi Medical University Nanning 530021, Guangxi Zhuang Autonomous Region, P. R. China.
Yong HuangNational Center for International Research of Biotargeting Theranotics, Guangxi Key Laboratory of Biotargeting Theranotics, Collaborative Innovation Center for Targeting Tumor Diagnosis and Therapy, Guangxi Medical University Nanning 530021, Guangxi Zhuang Autonomous Region, P. R. China.
Yongxiang ZhaoNational Center for International Research of Biotargeting Theranotics, Guangxi Key Laboratory of Biotargeting Theranotics, Collaborative Innovation Center for Targeting Tumor Diagnosis and Therapy, Guangxi Medical University Nanning 530021, Guangxi Zhuang Autonomous Region, P. R. China.
Theranostics (New Zealand) · NZ

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Life science research is advancing rapidly in the 21st century. Many innovative technologies and methodologies are being applied in various fields of the life sciences to reveal how macromolecules interact with each other. The technology of using fluorescent molecules in biomedical research has contributed immensely to progress in this field. Fluorescence-based optical biosensors, which show high specificity, exhibit huge potential for clinical diagnosis and treatment of many of the life-changing diseases. Fluorescence resonance energy transfer (FRET), is a technique that has been widely employed in biosensing ever since its discovery. It is a classic fluorescence technique, and an important biosensing research tool extensively utilized in the fields of toxicology, pharmacology, and biomedicine; many biosensor designs are based on FRET. Radiometric imaging of biological molecules, biomolecular interactions, and cellular processes are extensively performed using FRET biosensors. This review focuses on the selection of FRET donors and acceptors used for biosensing, and presents an overview of different FRET technologies. Furthermore, it highlights the progress in the application for FRET in nucleic acid and protein biosensing, and provides a viewpoint for future developmental trends using FRET technology.

Indexed as

Biosensingfluorescencefluorescent proteinsFRET

Identifiers

PMID36915763
PMCPMC10006758
OpenAlexW4324130262

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.